Selective mutation of Traf1/cIAP2 (V196) interaction attenuates inflammatory responses that may contribute to rheumatoid arthritis activity. THis may lead to a new class of therapies for RA https://t.co/kYqAqGsSEA https://t.co/JWUN6iTvxa
Links:
Breakthrough study discovers genetic mutation could be basis for novel treatmen…
https://buff.ly/j5a5iEY
Mar-03-2025
